News
About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...
Cystic fibrosis is an inherited condition that affects many body functions such as breathing, digestion and reproduction. The lifelong condition becomes more severe with age and the majority have ...
Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently ...
In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and superior in reducing sweat chloride compared to ...
NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...
Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...
Hundreds of people with cystic fibrosis are to be offered a once-a-day pill which has been hailed as “life changing” by ...
Sasha was diagnosed with cystic fibrosis (CF) at just six weeks. From the age of 14, she spent about 10 to 12 years in and out of hospital. “I’d be in hospital for three weeks and then maybe ...
Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...
Cystic fibrosis is a multi-system genetic disorder affecting the lungs, pancreas, liver and intestine. It can have a significant impact on life expectancy and quality of life. The current median age ...
In cystic fibrosis, thick mucus builds up in the lungs, making it difficult to breathe. This inherited disease, which is typically diagnosed by age 2, can also lead to frequent lung infections and ...
1d
WPBF Channel 25 on MSN‘On the Record’: Combating Cystic FibrosisA diagnosis led to a father going on a mission to fight cystic fibrosis. Get the latest news updates with the WPBF 25 News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results